ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $11,025,000 | +7.0% | 900,000 | 0.0% | 1.95% | +14.0% |
| Q2 2017 | $10,305,000 | -54.9% | 900,000 | -18.0% | 1.71% | -48.5% |
| Q1 2017 | $22,843,000 | -30.6% | 1,098,205 | -30.6% | 3.32% | -25.2% |
| Q4 2016 | $32,897,000 | -40.6% | 1,581,604 | -6.4% | 4.43% | -27.4% |
| Q3 2016 | $55,351,000 | +31.2% | 1,689,071 | 0.0% | 6.10% | +2.1% |
| Q2 2016 | $42,176,000 | +15.0% | 1,689,071 | +12.8% | 5.98% | +8.3% |
| Q1 2016 | $36,673,000 | +46.6% | 1,497,475 | +97.7% | 5.52% | +84.6% |
| Q4 2015 | $25,019,000 | +0.8% | 757,475 | 0.0% | 2.99% | -24.5% |
| Q3 2015 | $24,815,000 | -38.2% | 757,475 | 0.0% | 3.96% | -25.7% |
| Q2 2015 | $40,123,000 | +337.9% | 757,475 | +138.6% | 5.33% | +276.7% |
| Q1 2015 | $9,162,000 | +26.0% | 317,475 | +27.0% | 1.42% | +26.3% |
| Q4 2014 | $7,273,000 | +282.4% | 250,000 | +66.7% | 1.12% | +186.7% |
| Q3 2014 | $1,902,000 | -36.8% | 150,000 | 0.0% | 0.39% | -51.0% |
| Q2 2014 | $3,011,000 | – | 150,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |